Glial Fibrillary Acidic Protein Predicts Short-term Progression Independent of Relapse Activity in Primary Progressive Multiple Sclerosis

被引：0

作者：

Abdelhak, Ahmed ^{[1
,2
]}

Antweiler, Kai ^{[3
]}

Kowarik, Markus ^{[4
,5
]}

Senel, Makbule ^{[2
]}

Havla, Joachim ^{[6
]}

Zettl, Uwe K. ^{[7
]}

Kleiter, Ingo ^{[8
]}

Skripuletz, Thomas ^{[9
]}

Haarmann, Axel ^{[10
]}

Stahmann, Alexander ^{[11
]}

Huss, Andre ^{[2
]}

Gingele, Stefan ^{[9
]}

Krumbholz, Markus ^{[4
,5
,12
,13
]}

Kuhle, Jens ^{[14
,15
]}

Benkert, Pascal ^{[14
,15
]}

Friede, Tim ^{[3
]}

Ludolph, Albert C. ^{[2
]}

Ziemann, Ulf ^{[4
,5
]}

Kuempfel, Tania ^{[6
]}

Tumani, Hayrettin ^{[2
]}

机构：

[1] Univ Calif San Francisco UCSF, Dept Neurol, San Francisco, CA USA

[2] Univ Hosp Ulm, Dept Neurol, Ulm, Germany

[3] Univ Med Ctr Goettingen, Dept Med Stat, Gottingen, Germany

[4] Univ Tubingen Hosp, Dept Neurol & Stroke, Tubingen, Germany

[5] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany

[6] Ludwig Maximilians Univ Munchen, Inst Clin Neuroimmunol, LMU Hosp, Munich, Germany

[7] Univ Rostock, Neuroimmunol Sect, Dept Neurol, Rostock, Germany

[8] Behandlungszentrum Kempfenhausen Multiple Skleros, Marianne Strauss Klin, Berg, Germany

[9] Hannover Med Sch, Dept Neurol, Hanover, NH USA

[10] Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany

[11] Forsch & Projektentwicklungs gGmbH, MS Registry German MS Soc, Hanover, NH USA

[12] Univ Hosp Brandenburg, Brandenburg Med Sch Theodor Fontane, Dept Neurol & Pain Treatment, MS Ctr,Ctr Translat Med,Immanuel Klin Rudersdorf, Rudersdorf, Germany

[13] Brandenburg Med Sch Theodor Fontane, Fac Hlth Sci Brandenburg, Rudersdorf, Germany

[14] Univ Hosp Basel, Dept Clin Res, Basel, Switzerland

[15] Univ Hosp Basel, Dept Neurol, Basel, Switzerland

来源：

MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P632/1843

引用

页码：554 / 556

页数：3

共 50 条

[41] Olfactory threshold predicts short term relapse activity in relapsing-remitting multiple sclerosis
Bsteh, Gabriel
Nothegger, Lisa
Berek, Klaus
Ladstaetter, Felix
Raschbacher, Stefan
Wurth, Sebastian
Auer, Michael
Hegen, Harald
Di Pauli, Franziska
Deisenhammer, Florian
Reindl, Markus
Lutterotti, Andreas
Berger, Thomas
NEUROLOGY, 2017, 88
[42] Pathological cerebrospinal fluid protein concentration and albumin quotient at relapse predicts short-term disability progression in multiple sclerosis: a retrospective single center observational study
Diem, Lara
Burge, Maxine
Leichtle, Alexander
Hakim, Arsany
Chan, Andrew
Salmen, Anke
Evangelopoulos, Maria-Eleptheria
Hoepner, Robert
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020, 13
[43] Serum neurofilaments and glial fibrillary acid protein in progressive Multiple Sclerosis: a prospective longitudinal study
Ferraro, Diana
Mariotto, Sara
Cardi, Martina
Costantini, Riccardo Cuoghi
Del Giovane, Cinzia
Bedin, Roberta
Marcheselli, Simone
Smolik, Krzysztof
De Napoli, Giulia
Galota, Federica
Fiore, Alessia
Vitetta, Francesca
Ferrari, Sergio
Furlan, Roberto
Sola, Patrizia
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 593 - 594
[44] Inflammatory Activity on Natalizumab Predicts Short-Term but Not Long-Term Disability in Multiple Sclerosis
Raffel, Joel
Gafson, Arie R.
Dandaleh, Samer
Malik, Omar
Jones, Brynmor
Nicholas, Richard
PLOS ONE, 2017, 12 (01):
[45] Multidimensional measurement of progression independent of relapse activity in early multiple sclerosis
Braginets, Andre
Lin, Ting-Yi
Asseyer, Susanna
Ruprecht, Klemens
Paul, Friedemann
Schmitz-Huebsch, Tanja
Zimmermann, Hanna G.
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 448 - 449
[46] Cortical lesions as predictor of progression independent of relapse activity in multiple sclerosis
Pretzsch, Roxanne
Cagol, Alessandro
Ocampo-Pineda, Mario
Benkert, Pascal
Schaedelin, Sabine
Melie-Garcia, Lester
Weigel, Matthias
Yaldizli, Ozgur
Oechtering, Johanna
D'Souza, Marcus
Fischer-Barnicol, Bettina
Derfuss, Tobias
Lieb, Johanna M.
Leppert, David
Probstel, Anne-Katrin
Kappos, Ludwig
Sormani, Maria Pia
Kuhle, Jens
Granziera, Cristina
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 258 - 259
[47] Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression
Portaccio, Emilio
Betti, Matteo
De Meo, Ermelinda
Addazio, Ilaria
Pasto, Luisa
Razzolini, Lorenzo
Totaro, Rocco
Spitaleri, Daniele
Lugaresi, Alessandra
Cocco, Eleonora
Onofrj, Marco
Di Palma, Franco
Patti, Francesco
Maimone, Davide
Valentino, Paola
Clerici, Valentina Torri
Protti, Alessandra
Ferraro, Diana
Lus, Giacomo
Maniscalco, Giorgia Teresa
Morra, Vincenzo Brescia
Salemi, Giuseppe
Granella, Franco
Pesci, Ilaria
Bergamaschi, Roberto
Aguglia, Umberto
Vianello, Marika
Simone, Marta
Lepore, Vito
Iaffaldano, Pietro
Comi, Giancarlo
Filippi, Massimo
Trojano, Maria
Amato, Maria Pia
JOURNAL OF NEUROLOGY, 2024, 271 (08) : 5074 - 5082
[48] Plasma glial fibrillary acidic protein and neurofilament light chain in relation to disability worsening in multiple sclerosis
Pauwels, Ayla
Van Schependom, Jeroen
Devolder, Lindsay
Van Remoortel, Ann
Nagels, Guy
Bjerke, Maria
D'hooghe, Marie B.
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (11) : 1685 - 1696
[49] Serum Glial Fibrillary Acidic Protein (sGFAP) as potential biomarker for cognition and neuropsychiatric symptoms in multiple sclerosis?
Koelsche, Tristan
Renner, Alina
Aktas, Orhan
Baetge, Sharon
Filser, Melanie
Albrecht, Philipp
Steffen, Falk
Bittner, Stefan
Meuth, Sven
Pawlitzki, Marc
Penner, Iris-Katharina
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 970 - 971
[50] Serum Neurofilament Light Chain (NfL) and CSF Glial Fibrillary Acidic Protein (GFAP) Together Improve the Prediction of Long-Term Clinical Progression in Multiple Sclerosis
Thebault, S.
Bose, G.
Fereshtehnejad, S.
Bergman, H.
Booth, R. A.
Freedman, M. S.
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 37 - 37

← 1 2 3 4 5 →